Comparative in-vitro activity of cefpirome against isolates from intensive care and haematology/oncology units

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 4, 1998, Pages 443-450

  Piérard, Denis ^a   Emmerechts, Kristof ^a   Lauwers, Sabine ^a   Carpentier, M ^b   Delmee M ^c   Demol, P ^b   Mertens, H ^d   Meunier, F ^e   Struelens, M ^f   Surmont, I ^g   Van Noyen, R ^h   Verbist, L ⁱ   Verschraegen, G ^j  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d St Jansziekenhuis   (Belgium)

^e Hospital de Jolimont   (Belgium)

^f ERASME HOSPITAL   (Belgium)

^g Heilig Hart Ziekenhuis   (Belgium)

^h IMELDA HOSPITAL   (Belgium)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ENTEROBACTERIACEAE; ENTEROCOCCUS; HOSPITAL; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

BETA-LACTAM RESISTANCE; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HEMATOLOGY; HOSPITAL UNITS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; ONCOLOGY SERVICE, HOSPITAL;

EID: 15444343016     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.4.443     Document Type: Article

References (15)

1. Péchère, J. C., Wilson, W. & Neu, H. (1995). Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. Journal of Antimicrobial Chemotherapy 36, 757-71.
2. Chandrasekar, P. H. & Alangaden, G. J. (1996). Newer beta-lactam antibiotics. Current Opinion in Infectious Diseases 9, 391-7.
3. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition. Approved Standard M7-A2. NCCLS, Wayne, PA.
4. Jarlier, V., Nicolas, M.-H., Fournier, G. & Philippen, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 10, 867-78.
5. Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F. & Gaynes, R. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clinical Infectious Diseases 24, 211-5.
6. Bryskier, A. (1997). New concepts in the field of cephalosporins: C-3′ quaternary ammonium cephems (Group IV). Clinical Microbiology and Infection 3, Suppl. 1, 1-6.
7. Watanabe, N. A. (1996). Newer antipseudomonal cephalosporins. Journal of Chemotherapy 8, Suppl. 2, 48-56.
8. Bert, F., Briaud, I., Branger, C., & Lambert Zechovsky, N. (1996). Comparaison de l'activité des beta-lactamines sur Pseudomonas aeruginosa en fonction des phenotypes de resistance. Pathologie Biologie 44, 329-32.
9. Gargalianos, P., Oppenheim, B. A., Skepastianos, P., Livermore, D. M. & Williams, R. J. (1988). Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 22, 841-8.
10. Johnson, C. C., Livornese, L., Gold, M. J., Pitsakis, P. G., Taylor, S. & Levison, M. E. (1995). Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula. Journal of Antimicrobial Chemotherapy 35, 765-73.
11. Sanders, W. E., Tenney, J. H. & Kessler, R. E. (1996). Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clinical Infectious Diseases 23, 454-61.
12. Sanders, C. C. (1996). In-vitro activity of fourth-generation cephalosporins against Enterobacteriaceae producing extended-spectrum beta-lactamases. Journal of Chemotherapy 8, Suppl. 2, 57-62.
13. Gordts, B., Van Landuyt, H., Leven, M., Vandamme, P. & Goossens, H. (1995). Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. Journal of Clinical Microbiology 33, 2842-6.
14. Klugman, K., Goldstein, F., Kohno, S. & Baquero, F. (1997). The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clinical Microbiology and Infection 3, Suppl. 1, 48-60.
15. Garau, J., Wilson, W., Wood, M. & Carlet, J. (1997). Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility. Clinical Microbiology and Infection 3, Suppl. 1, 87-101.